Sep. 24, 2024 — Parkinson's disease, a debilitating nervous system disorder, is treated with medications that sometimes cause impaired decision-making and poor ... Some Diabetes Drugs Tied to ...

A new study has revealed that the widely prescribed Parkinson's disease drug entacapone significantly disrupts the human gut microbiome by inducing iron deficiency. The research was conducted ...

Parkinson's drug linked to harmful gut microbiome changes, potentially caused by iron deficiency, may worsen gut health and impact treatment outcomes. A new study reveals a surprising side effect ...

Parkinson’s drug, entacapone, induces iron deficiency, which alters the gut microbiome and triggers the growth of potentially harmful bacteria like E. coli, reports a new study. The findings mean that ...

Summary: The Parkinson’s drug entacapone disrupts the gut microbiome by inducing iron deficiency, favoring the growth of potentially harmful bacteria like E. coli. Using advanced molecular techniques, ...

Sanofi has joined a growing list of drugmakers going after alpha-synuclein targeting drugs for Parkinson's disease, licensing a bispecific antibody from South Korea's ABL Bio in a deal that could ...

While there are medications that control the disease's motor symptoms, there are no effective treatments for its cognitive symptoms. "When patients are diagnosed with Parkinson's disease ...

have revealed that the widely prescribed Parkinson's disease drug entacapone significantly disrupts the human gut microbiome by inducing iron deficiency. The study, published in Nature ...

The Vyafuser pump maintains a continuous, steady flow of the drug throughout the day and can be refilled at home by patients or their carers. "People living with advanced Parkinson's disease ...

A large case-control study suggests that calcium channel blockers are the only antihypertensives that reduce the risk for Parkinson disease ... of antihypertensive drugs: angiotensin-converting ...